Recent studies have indicated that bone morphogenetic protein-6 (BMP-6) and its receptors are present in adult and fetal brain. BMP-6 is important in neuronal differentiation during embryonic development. The functions of this trophic factor in the adult brain are still not known. The purpose of this study was to examine the neuroprotective effect of BMP-6 in an ischemia/reperfusion injury model. BMP-6 or vehicle was injected directly into 3 sites in the right cerebral cortex 30 min before right middle cerebral artery (MCA) ligation in chloral hydrate anesthetized rats. We, and others, have previously reported that transient ligation of MCA for 60 minutes at its first bifurcation above zygomatic arch generates distal ischemia. Animals developed body asymmetry and cortical infarction 48 hours after reperfusion. We found that animals receiving BMP-6 pretreatment had less motor asymmetry, and more locomotor activity. Some animals were sacrificed 48 hours after ischemia for histological examination. TUNEL (+) cells and Caspase-3 immunoreactivity, indicative of apoptosis in the ischemic penumbra, were significantly reduced in rats pretreated with BMP-6. The volume of infarction, as measured after TTC staining, was also significantly reduced in BMP-6 pretreated rats. Taken together, our data indicate that pretreatment with BMP-6 protects against ischemia/reperfusion insults, possibly through an anti-apoptotic mechanism.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000429-02
Application #
6431965
Study Section
(CNRL)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chou, J; Luo, Y; Kuo, C-C et al. (2008) Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 151:92-103
Chen, Yuan-Hao; Harvey, Brandon K; Hoffman, Alexander F et al. (2008) MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector. FASEB J 22:261-75
Harvey, B K; Chen, G J; Schoen, C J et al. (2007) An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of stroke. Cell Transplant 16:483-91
Chen, Guann-Juh; Harvey, Brandon K; Shen, Hui et al. (2006) Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J Neurosci Res 84:1848-55
Woods, Amina S; Kaminski, Rafal; Oz, Murat et al. (2006) Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. J Proteome Res 5:1017-23
Harvey, Brandon K; Hoffer, Barry J; Wang, Yun (2005) Stroke and TGF-beta proteins: glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacol Ther 105:113-25
Harvey, B K; Mark, A; Chou, J et al. (2004) Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res 1022:88-95
Cox, Suyu; Harvey, Brandon K; Sanchez, Joseph F et al. (2004) Mediation of BMP7 neuroprotection by MAPK and PKC IN rat primary cortical cultures. Brain Res 1010:55-61
Harvey, B K; Chang, C F; Chiang, Y H et al. (2003) HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol 183:47-55
Chang, Chen-Fu; Lin, Shinn-Zong; Chiang, Yung-Hsiao et al. (2003) Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558-64

Showing the most recent 10 out of 11 publications